Revolution Medicines director Lorence H. Kim disposes of common shares worth $11.21 million
RVMD•Director share sale reported
- Revolution Medicines director Lorence H. Kim sold 56,000 common shares on Aug. 31 at about $200.56–$206.15.
- Sales were reported as indirect holdings through a trust, with post-transaction trust ownership of 17,090 shares.
